Author:
Tosco L,Laenen A,Briganti A,Gontero P,Karnes R J,Albersen M,Bastian P J,Chlosta P,Claessens F,Chun F K,Everaerts W,Gratzke C,Graefen M,Kneitz B,Marchioro G,Salas R S,Tombal B,Van den Broeck T,Moris L,Battaglia A,van der Poel H,Walz J,Bossi A,De Meerleer G,Haustermans K,Van Poppel H,Spahn M,Joniau S,
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference23 articles.
1. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol 2017; 71: 618–629.
2. Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV et al. Prostate cancer, version 2.2014. J Natl Compr Canc Netw 2014; 12: 686–718.
3. Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD . Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev. 2006; 4: CD006019.
4. Bartek J, Mistrik M, Bartkova J . Androgen receptor signaling fuels DNA repair and radioresistance in prostate cancer. Cancer Discov 2013; 3: 1222–1224.
5. Al-Ubaidi FL, Schultz N, Loseva O, Egevad L, Granfors T, Helleday T . Castration therapy results in decreased Ku70 levels in prostate cancer. Clin Cancer Res. 2013; 19: 1547–1556.